We wish to inform you that at the Board Meeting held today i.e. on Thursday, May 23, 2024, the Board of Directors of the Company have inter alia Considered and approved the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year Ended 31st March, 2024. we are enclosing herewith: a. Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year Ended 31st March, 2024. b. Statement of Assets and Liabilities as at March 31, 2024 and Statement of Cash Flows for the Financial Year Ended 31st March, 2024. c. Declaration pursuant to Regulation 33(3) (d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the Annual Financial Results for the Financial Year ended on 31st March, 2024. d. Auditors reports on the Audited Financial Results on Standalone and Consolidated basis.

pdf

Kwality Pharmaceuticals Ltd.

23 May 2024

828.50

-5.42%

Result

Kwality Pharmaceuticals Ltd - 539997 - FINANCIAL RESULTS FOR THE QTR AND YEAR ENDED 31ST MARCH …

BSE India

AUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED 31-03-2024 ALONGWITH OTHER NECESSARY ANNEXURES ARE ATTACHED HEREWITH

pdf

Kwality Pharmaceuticals Ltd.

08 May 2024

828.50

-5.42%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Considering The Standalone & Consolidated Audited …

BSE India

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 ,inter alia, to consider and approve the Standalone & Consolidated audited financial results for the fourth quarter and financial year ended on 31st March, 2024.Further, as per our earlier communication vide our letter dated 30th March, 2024 and in accordance with the Company's Code of Conduct for Prohibition of Insider Trading framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading window for dealing in Securities of the Company for all the Board of Directors, Designated Persons and their immediate relatives will remain closed till 48 hours after the financial results of the Company are made public on May 23, 2024.This is for your information and record.

pdf